Department Of Medicine 8
351. The association of VDR gene polymorphisms with serum vitamin D levels and injury predisposition in elite athletes of Kazakhstan
352. Correction to: SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and posthospital mortality (BMC Infectious Diseases, (2021), 21, 1, (458), 10.1186/s12879-021-06154-z)
353. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality
354. Short-term effect of ldl-apheresis on lipid profile of patients with nephrotic and non-nephrotic hyperlipidemia: A comparative study
355. Urinary Protein Profiling for Potential Biomarkers of Chronic Kidney Disease: A Pilot Study
356. Urinary Protein Profiling for Potential Biomarkers of Chronic Kidney Disease: A Pilot Study
357. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis
358. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
359. Epidemiology of type 1 diabetes mellitus in children in Kazakhstan: Data from unified national electronic health system 2014-2021
360. Reliability of pressure-volume loop parameters derived from transthoracic echocardiography in patients undergoing hemodialysis
361. Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis
362. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
363. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
364. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
365. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
366. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
367. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
368. Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma?
369. Prevalence of Smoking Various Tobacco Types in the Kazakhstani Adult Population in 2021: A Cross-Sectional Study
370. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
371. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
372. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
373. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
374. Evaluating the impact of the diabetes mellitus strategy for the national health system: An interrupted time series analysis
375. Academic motivation and self-directed learning readiness of nursing students during the COVID-19 pandemic in three countries: A cross-sectional study
376. Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial
377. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
378. Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches
379. Understanding the Role of Sex Hormones in Cardiovascular Kidney Metabolic Syndrome: Toward Personalized Therapeutic Approaches
380. Combating the menace of antimicrobial resistance in Africa: a review on stewardship, surveillance and diagnostic strategies
381. Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence
382. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
383. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
384. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
385. Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner
386. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
387. Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas
388. Monkeypox: Is the world ready for another pandemic?
389. Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan
390. Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan
391. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
392. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
393. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
394. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
395. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
396. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
397. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
398. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
399. Validation of a Kazakhstani Version of the Mental Health Continuum—Short Form
400. Global evolution of inflammatory bowel disease across epidemiologic stages
1 6 7 8 9 10 24